Entrada Therapeutics, Inc. (TRDA)
6.56
-0.55
(-7.74%)
USD |
NASDAQ |
Sep 10, 12:27
Entrada Therapeutics 1 Year Total Returns (Daily) : 38.33% for Sept. 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 09, 2026 | 38.33% |
| September 08, 2026 | 42.42% |
| September 04, 2026 | 36.59% |
| September 03, 2026 | 34.77% |
| September 02, 2026 | 35.69% |
| September 01, 2026 | 29.25% |
| August 31, 2026 | 28.88% |
| August 28, 2026 | 23.89% |
| August 27, 2026 | 27.99% |
| August 26, 2026 | 24.78% |
| August 25, 2026 | 35.35% |
| August 24, 2026 | 19.38% |
| August 21, 2026 | 28.96% |
| August 20, 2026 | 43.13% |
| August 19, 2026 | 38.43% |
| August 18, 2026 | 31.70% |
| August 17, 2026 | 38.90% |
| August 14, 2026 | 42.10% |
| August 13, 2026 | 40.04% |
| August 12, 2026 | 48.64% |
| August 11, 2026 | 40.24% |
| August 10, 2026 | 33.91% |
| August 07, 2026 | 29.62% |
| August 06, 2026 | 15.46% |
| August 05, 2026 | 21.10% |
| Date | Value |
|---|---|
| August 04, 2026 | 22.30% |
| August 03, 2026 | 25.17% |
| July 31, 2026 | 15.48% |
| July 30, 2026 | 1.96% |
| July 29, 2026 | 4.13% |
| July 28, 2026 | -6.42% |
| July 27, 2026 | -7.03% |
| July 24, 2026 | -8.45% |
| July 23, 2026 | -5.32% |
| July 22, 2026 | -3.60% |
| July 21, 2026 | 5.21% |
| July 20, 2026 | 1.28% |
| July 17, 2026 | 7.99% |
| July 16, 2026 | 7.68% |
| July 15, 2026 | 11.62% |
| July 14, 2026 | 0.00% |
| July 13, 2026 | 0.76% |
| July 10, 2026 | 2.37% |
| July 09, 2026 | -2.25% |
| July 08, 2026 | 2.23% |
| July 07, 2026 | 6.89% |
| July 06, 2026 | 4.15% |
| July 02, 2026 | 6.19% |
| July 01, 2026 | 6.75% |
| June 30, 2026 | 9.52% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 198.0% |
| Oncolytics Biotech, Inc. | -42.81% |
| Sangamo Therapeutics, Inc. | -70.18% |
| Sarepta Therapeutics, Inc. | 24.83% |
| Anixa Biosciences, Inc. | -5.03% |